Patient consultation: Can patients with liver cancer still undergo liver transplant? A few days ago, I always felt uncomfortable with the liver, a little pain, I was unwilling to eat, my face turned yellow, and I went to the hospital for CT examination . The result was that liver cancer was advanced and could no longer be treated surgically. I would like to ask if patients with liver cancer can undergo liver transplantation?
Can patients with liver cancer still undergo liver transplantation? Certain conditions need to be met
For the question of "Can patients with liver cancer still undergo liver transplantation?", we asked the liver disease experts to point out:
Generally speaking, primary hepatocellular carcinoma and cholangiocellular liver cancer can be treated through liver transplantation, and Chinese medicine is used after the operation to help patients recover and inhibit the spread and growth of cancer cells.
However, for the vast majority of liver cancer patients, liver transplantation is not recommended for treatment. This is mainly because most liver cancer patients are not suitable for liver transplant surgery. Can liver cancer patients still undergo liver transplantation? It is necessary to make a comprehensive decision based on the patient's own tolerance and treatment process.
For those who have no surgical indications and cannot undergo surgery, patients give up the surgery, or after the surgery, for radiotherapy, chemotherapy or interventional treatment in , or after treatment, or without chemotherapy, radiotherapy, or interventional treatment, traditional Chinese medicine treatment is an excellent choice.
In recent years, traditional Chinese medicine has played an important role in the comprehensive treatment of primary liver cancer . Traditional Chinese medicine treatment is characterized by no obvious adverse reactions and low price. This can be used to treat patients' specific cancer condition and physical condition, and to treat them in a targeted manner, to clear and reduce cancer toxins, and to regulate and nourish the internal organs and qi and blood.
For most patients with middle- and advanced liver cancer who cannot undergo surgical treatment, traditional Chinese medicine can be used to treat liver tumors. The use of "GS-N targeted therapy for clearing and nourishing toxins" combined with Chinese patent medicines in the hospital can eliminate hypersplenia, prevent bleeding, reduce portal hypertension, and inhibit tumor development.
Hepatitis B's "small three positive" carcinogenic effect is much greater than " Big three positive "
Shaanxi Hepatitis Association's " Health News " once made a very meaningful investigation report. The report pointed out that the number of people with liver cancer has been rising in recent years. From the perspective of the development of liver cancer, hepatitis B's "small three positive" surpasses the "big three positive", and is the first to be the "culprit" of cancer.
Shaanxi Hepatology Association recently tested confirmed primary liver cancer and learned shocking data. Only 6.2% of those who were negative for "two to half" were negative, that is, 93.8% of liver cancers were related to hepatitis B virus infection.
Among them, hepatitis B "minor three positive" accounts for more than 60% of the total number of liver cancer, while the major three positive patients have less than 10%.
Why is Xiao Sanyang more likely to become cancerous than Da Sanyang?
"Xiao Sanyang" belongs to the recovery period of acute infection of hepatitis B virus, and its clinical symptoms are not obvious and are easily overlooked. However, the speed of virus replication in the body has not been reduced. Since people ignore the virus that causes the hepatitis B virus to evade the attack of immune cells , the virus that is not "surveillance" will cause trouble, and the probability of evolving into cancer cells is greatly increased, so the "little Sanyang" is by no means safe.
Whether it is "big three yang" or "small three yang", it only reflects the condition of the virus carriage in the human body, and cannot reflect the damage to the liver, so it cannot be used to judge the severity of the disease. Therefore, patients with "little three-yang" cannot rest assured.
In addition, since the development of Xiao Sanyang is more concealed, the treatment of Hepatitis B Xiao Sanyang is first necessary to go to a regular hospital for effective testing and examination as soon as possible to clarify the root of the disease, and only symptomatic treatment can easily cure the disease.
Xi'an Peking University Liver Disease Research Institute has been committed to liver disease research and diagnosis and treatment, and has been well received by patients. It has a new patented liver treatment technology with the trinity of "prevention-treatment-health", regularly conducts consultations with experts on difficult liver diseases, establishes long-term cooperation with Beijing 302 Hospital to maintain technology synchronization, and allows patients with liver disease to enjoy the best quality diagnosis and treatment. Click the blue link below to make an appointment directly:
Xi'an Peking University Liver Disease Research Institute
